154 related articles for article (PubMed ID: 35744511)
1. Loop-Mediated Isothermal Amplification as Point-of-Care Testing for
Saito Y; Matsui A; Michiyuki S; Morooka H; Ibi T; Yamauchi Y; Takahashi N; Shimizu Y; Ikeya T; Hoshi E; Sakao Y; Kawamura M
Micromachines (Basel); 2022 Jun; 13(6):. PubMed ID: 35744511
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the loop-mediated isothermal amplification method and the QIAGEN
Saito Y; Takahashi N; Matsui A; Michiyuki S; Yamauchi Y; Shimizu Y; Hoshi E; Sakao Y; Kawamura M
J Thorac Dis; 2021 Feb; 13(2):743-753. PubMed ID: 33717546
[TBL] [Abstract][Full Text] [Related]
3. A novel loop‑mediated isothermal amplification method for efficient and robust detection of EGFR mutations.
Horiuchi S; Saito Y; Matsui A; Takahashi N; Ikeya T; Hoshi E; Shimizu Y; Yasuda M
Int J Oncol; 2020 Mar; 56(3):743-749. PubMed ID: 32124949
[TBL] [Abstract][Full Text] [Related]
4. Detection of epidermal growth factor receptor T790M mutation by allele-specific loop mediated isothermal amplification.
Arjuna S; Chakraborty G; Venkataram R; Dechamma PN; Chakraborty A
J Carcinog; 2020; 19():3. PubMed ID: 32684851
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive detection of EGFR mutations by cell-free loop-mediated isothermal amplification (CF-LAMP).
Arjuna S; Venkataram R; Dechamma PN; Chakraborty G; Babu N; D'Cruz A; Hosmane GB; Chakraborty A
Sci Rep; 2020 Oct; 10(1):17559. PubMed ID: 33067539
[TBL] [Abstract][Full Text] [Related]
6. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.
Garcia J; Wozny AS; Geiguer F; Delherme A; Barthelemy D; Merle P; Tissot C; Jones FS; Johnson C; Xing X; Xu Z; Edelstein DL; Brevet M; Souquet PJ; Rodriguez-Lafrasse C; Payen L; Couraud S
Cancer Med; 2019 Jul; 8(8):3685-3697. PubMed ID: 31112372
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
He C; Wei C; Wen J; Chen S; Chen L; Wu Y; Shen Y; Bai H; Zhang Y; Chen X; Li X
J Cancer Res Clin Oncol; 2022 Feb; 148(2):321-330. PubMed ID: 34693477
[TBL] [Abstract][Full Text] [Related]
8. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
[TBL] [Abstract][Full Text] [Related]
10. Complementing Tissue Testing With Plasma Mutation Profiling Improves Therapeutic Decision-Making for Patients With Lung Cancer.
Choudhury Y; Tan MH; Shi JL; Tee A; Ngeow KC; Poh J; Goh RR; Mong J
Front Med (Lausanne); 2022; 9():758464. PubMed ID: 35223889
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer.
Zhang Y; Xiong L; Xie F; Zheng X; Li Y; Zhu L; Sun J
Cancer Med; 2021 Jul; 10(14):4697-4709. PubMed ID: 34173341
[TBL] [Abstract][Full Text] [Related]
12. Rapid diagnosis of lymph node metastasis in lung cancer with loop-mediated isothermal amplification assay using carcinoembryonic antigen-mRNA.
Maeda J; Inoue M; Nakabayashi K; Otomo Y; Shintani Y; Ohta M; Okumura M; Matsuura N
Lung Cancer; 2009 Sep; 65(3):324-7. PubMed ID: 19144442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
[TBL] [Abstract][Full Text] [Related]
14. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
Li Y; Zhang FS; Guo L; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
[No Abstract] [Full Text] [Related]
15. CONCORDANCE: A real-world evidence study to evaluate the concordance of detecting epidermal growth factor receptor (EGFR) mutation by circulating tumor DNA* versus tissue biopsy in patients with metastatic non-small cell lung cancer.
Prabhash K; Biswas B; Khurana S; Batra U; Biswas G; Advani SH; Mohapatra PN; Rajappa S; Sharma A; Patil S; Dattatreya PS; Roy R; Almel S; Goyal G; Warrier N
Indian J Cancer; 2022 Mar; 59(Supplement):S11-S18. PubMed ID: 35343188
[TBL] [Abstract][Full Text] [Related]
16. Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer.
Kimura H; Ohira T; Uchida O; Matsubayashi J; Shimizu S; Nagao T; Ikeda N; Nishio K
Lung Cancer; 2014 Mar; 83(3):329-33. PubMed ID: 24439568
[TBL] [Abstract][Full Text] [Related]
17. Detection of EGFR mutations in liquid biopsy samples using allele-specific quantitative PCR: A comparative real-world evaluation of two popular diagnostic systems.
Szpechcinski A; Bryl M; Wojcik P; Czyzewicz G; Wojda E; Rudzinski P; Duk K; Moes-Sosnowska J; Maszkowska-Kopij K; Langfort R; Barinow-Wojewodzki A; Chorostowska-Wynimko J
Adv Med Sci; 2021 Sep; 66(2):336-342. PubMed ID: 34274564
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of CALR type 1 and type 2 mutations using PNA-LNA clamping loop-mediated isothermal amplification on a CD-like microfluidic chip.
Cao G; Kong J; Xing Z; Tang Y; Zhang X; Xu X; Kang Z; Fang X; Guan M
Anal Chim Acta; 2018 Sep; 1024():123-135. PubMed ID: 29776538
[TBL] [Abstract][Full Text] [Related]
19. Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib.
Ding PN; Becker T; Bray V; Chua W; Ma Y; Xu B; Lynch D; de Souza P; Roberts T
Thorac Cancer; 2019 Oct; 10(10):1879-1884. PubMed ID: 31414729
[TBL] [Abstract][Full Text] [Related]
20. Detection of
Matsumoto N; Kumasaka A; Ando T; Komiyama K
Anticancer Res; 2018 Apr; 38(4):2093-2099. PubMed ID: 29599327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
